These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38237586)

  • 41. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
    Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
    Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system.
    Ostermann PN; Schaal H
    Rev Med Virol; 2023 Mar; 33(2):e2430. PubMed ID: 36790825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside.
    Emmi A; Boura I; Raeder V; Mathew D; Sulzer D; Goldman JE; Leta V
    Int Rev Neurobiol; 2022; 165():17-34. PubMed ID: 36208899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
    Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
    J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of Hamsters.
    Zhang AJ; Lee AC; Chu H; Chan JF; Fan Z; Li C; Liu F; Chen Y; Yuan S; Poon VK; Chan CC; Cai JP; Wu KL; Sridhar S; Chan YS; Yuen KY
    Clin Infect Dis; 2021 Jul; 73(2):e503-e512. PubMed ID: 32667973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human stem cell models to study host-virus interactions in the central nervous system.
    Harschnitz O; Studer L
    Nat Rev Immunol; 2021 Jul; 21(7):441-453. PubMed ID: 33398129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on neurological manifestations of COVID-19.
    Yavarpour-Bali H; Ghasemi-Kasman M
    Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Directed dopaminergic neuron differentiation from human pluripotent stem cells.
    Zhang P; Xia N; Reijo Pera RA
    J Vis Exp; 2014 Sep; (91):51737. PubMed ID: 25285746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).
    Payus AO; Liew Sat Lin C; Mohd Noh M; Jeffree MS; Ali RA
    Bosn J Basic Med Sci; 2020 Aug; 20(3):283-292. PubMed ID: 32530389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids
    Kim MJ; Kim S; Kim H; Gil D; Han HJ; Thimmulappa RK; Choi JH; Kim JH
    Emerg Microbes Infect; 2023 Dec; 12(1):2211685. PubMed ID: 37161660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways.
    Surendran H; Kumar S; Narasimhaiah S; Ananthamurthy A; Varghese PS; D'Souza GA; Medigeshi G; Pal R
    J Cell Physiol; 2022 Jul; 237(7):2913-2928. PubMed ID: 35460571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells.
    Iwanski J; Kazmouz SG; Li S; Stansfield B; Salem TT; Perez-Miller S; Kazui T; Jena L; Uhrlaub JL; Lick S; Nikolich-Žugich J; Konhilas JP; Gregorio CC; Khanna M; Campos SK; Churko JM
    Stem Cell Reports; 2021 Oct; 16(10):2459-2472. PubMed ID: 34525378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 and the DNA damage response.
    Grand RJ
    J Gen Virol; 2023 Nov; 104(11):. PubMed ID: 37948194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19.
    Beckman D; Bonillas A; Diniz GB; Ott S; Roh JW; Elizaldi SR; Schmidt BA; Sammak RL; Van Rompay KKA; Iyer SS; Morrison JH
    Cell Rep; 2022 Nov; 41(5):111573. PubMed ID: 36288725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53.
    Lee JD; Menasche BL; Mavrikaki M; Uyemura MM; Hong SM; Kozlova N; Wei J; Alfajaro MM; Filler RB; Müller A; Saxena T; Posey RR; Cheung P; Muranen T; Heng YJ; Paulo JA; Wilen CB; Slack FJ
    Cell Rep; 2023 Dec; 42(12):113478. PubMed ID: 37991919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.